These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28442193)

  • 21. Hidradenitis suppurativa in children: The Henry Ford experience.
    Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
    Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity.
    Martorell A; García-Martínez FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodriguez J; Salgado L; Vilarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):703-15. PubMed ID: 26254550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated body mass index, a risk factor or consequence of hidradenitis suppurativa?
    Orenstein LAV
    Br J Dermatol; 2021 Jul; 185(1):6-7. PubMed ID: 33755195
    [No Abstract]   [Full Text] [Related]  

  • 24. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidradenitis suppurativa.
    Jemec GB
    J Cutan Med Surg; 2003; 7(1):47-56. PubMed ID: 12457209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review.
    Casseres RG; Kahn JS; Her MJ; Rosmarin D
    J Am Acad Dermatol; 2019 Jul; 81(1):265-267. PubMed ID: 30562567
    [No Abstract]   [Full Text] [Related]  

  • 27. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
    Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
    Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative pressure dressings for severe hidradenitis suppurativa (acne inversa): a case report.
    Walls B; Mohammad S; Campbell J; Archer L; Beale J
    J Wound Care; 2010 Oct; 19(10):457-60. PubMed ID: 20948495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hidradenitis suppurativa: a review of cause and treatment.
    Yazdanyar S; Jemec GB
    Curr Opin Infect Dis; 2011 Apr; 24(2):118-23. PubMed ID: 21192260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.
    van der Zee HH; Laman JD; Boer J; Prens EP
    Exp Dermatol; 2012 Oct; 21(10):735-9. PubMed ID: 22882284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2017 Jan; 76(1):54-59. PubMed ID: 27692736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidradenitis Suppurativa After Radical Surgery-Long-Term Follow-up for Recurrences and Associated Factors.
    Walter AC; Meissner M; Kaufmann R; Valesky E; Pinter A
    Dermatol Surg; 2018 Oct; 44(10):1323-1331. PubMed ID: 30204742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 34. A 12-Year Experience of Hidradenitis Suppurativa Management.
    Vankeviciute RA; Polozovaite B; Trapikas J; Raudonis T; Grigaitiene J; Bylaite-Bucinskiene M
    Adv Skin Wound Care; 2019 Jan; 32(1):1-7. PubMed ID: 30570558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hidradenitis suppurativa and psoriasis: manifestation of a hidden disease].
    Bouaddi M; Hassam B
    Pan Afr Med J; 2017; 27():200. PubMed ID: 28904725
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of Itch and Pain on Sleep Quality in Patients with Hidradenitis Suppurativa.
    Kaaz K; Szepietowski JC; Matusiak Ł
    Acta Derm Venereol; 2018 Aug; 98(8):757-761. PubMed ID: 29756157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-cause mortality among patients with hidradenitis suppurativa: A population-based cohort study in the United States.
    Reddy S; Strunk A; Garg A
    J Am Acad Dermatol; 2019 Oct; 81(4):937-942. PubMed ID: 31202872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidradenitis suppurativa scoring systems: can we choose just one?
    Porter ML; Kimball AB
    Cutis; 2017 Mar; 99(3):156-157. PubMed ID: 28398416
    [No Abstract]   [Full Text] [Related]  

  • 40. Passive smoking and hidradenitis suppurativa: a retrospective analysis.
    Aparício Martins I; Valente C; Simões Farinha P; Figueira Vilela B; Cabete J
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e466-e467. PubMed ID: 36306405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.